If you’re unfamiliar with Matthew Autterson, he is the President and CEO of CNS Biosciences, a company predicated on the development of pharmacotherapies aimed at treating neuropathic pain. Prior to his role with CNS Biosciences, Autterson spent a great deal of time in the financial sector, including 19-years with the Resources Trust Company. During his time with the company, Autterson oversaw the depository and custodial services of more than 200,000 clients and managed a team of roughly 15,000 registered financial advisors. As the company’s President, Autterson was also heavily involved in a series of acquisitions that beset the Company, including its acquisition by AIG in 1998, and the subsequent acquisition by Fiserv in 2001.
Matthew Autterson is a Michigan State University alumnus, who earned a Bachelor’s degree in Finance in 1979, before going on to attend the Graduate Tax Program at the University of Denver. After completing his studies, and beginning his career with the Resources Trust Company, Autterson later joined GL3B Partners Limited in 2001, a business consulting firm specializing in investment partnerships, privately-held companies, and real estate. Although his latest role with CNS Biosciences represents a considerable shift in his career trajectory, it is one that Autterson is more than capable of excelling at. See More Info Here.
Autterson has been a member of the board of directors for Falci Adaptive Systems since 2013, and as a result, has gained a great deal of insight into the bioscience world. According to the company’s Linkedin bio, Falci Adaptive Systems is a non-profit company predicated on providing assistance to those who suffer from neuromotor disabilities. Matthew Autterson is also a member of the board of directors for Webb-Waring Foundation, a staunch supporter of biomedical research in Colorado. Additionally, Autterson serves as the Chairman of the board of directors for the Denver Hospice.
Matthew Autterson prides himself on continuously expanding his knowledge base when it comes to business, which explains his role as the former member and finance chairman for the Rocky Mountain Chapter of YPO. If you’re unfamiliar with YPO, it is an international platform comprised of more than 24,000 members who routinely come together to exchange ideas, inspire business, and most importantly, impact their respective communities. If Autterson’s past success is indicative of future results, it’ probably safe to say that we will be hearing more about him, and his latest role with CNS Biosciences, in the near future.